Summary & Overview
CPT 59015: Chorionic Villus Sampling (CVS) for Chromosomal Testing
CPT code 59015 designates chorionic villus sampling (CVS), an invasive prenatal diagnostic procedure to obtain placental tissue for chromosomal analysis. CVS is performed transvaginally or transabdominally and is clinically important for early detection of chromosomal abnormalities, influencing pregnancy management and genetic counseling. Nationally, the code is relevant across public and private payers due to its clinical implications and utilization in prenatal care.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical service, typical sites of service, and the procedural context for billing. The publication provides benchmarks where available, outlines common billing modifiers and administrative considerations, and summarizes policy and coverage themes affecting authorization, documentation, and medical necessity for CVS. Additionally, the resource highlights coding relationships and potential billing scenarios relevant to prenatal diagnostic workflows.
This summary is intended for clinicians, billing professionals, and policy analysts seeking a national-level reference for coding, coverage considerations, and clinical context related to CPT code 59015. Data not available in the input will be noted in the detailed sections.
Billing Code Overview
CPT code 59015 describes chorionic villus sampling (CVS), a prenatal diagnostic procedure in which the provider obtains a sample of chorionic villi from the placenta to test for chromosomal abnormalities. The procedure may be performed transvaginally or transabdominally depending on gestational age, anatomy, and provider approach.
Service type: Diagnostic prenatal invasive procedure
Typical site of service: Hospital outpatient department, ambulatory surgery center, or specialized prenatal clinic
Clinical & Coding Specifications
Clinical Context
A 34-year-old pregnant patient at 11 weeks gestation with a prior child affected by a chromosomal abnormality and a positive first‑trimester screening result is referred for diagnostic genetic testing. After counseling by maternal‑fetal medicine, the patient elects chorionic villus sampling. The procedure is performed either transabdominally under ultrasound guidance or transvaginally when placental location or maternal habitus dictates. Preprocedure steps include informed consent, review of maternal Rh status and administration of Rh immune globulin if indicated, baseline vital signs, and sterile preparation. Under continuous ultrasound visualization, the provider advances a needle (transabdominal) or catheter (transcervical/transvaginal) to obtain chorionic villi samples from the placenta, sends specimens to cytogenetics/microarray, and monitors the patient for complications such as bleeding or cramping. Typical site of service is an outpatient ambulatory surgery center or hospital outpatient department; the service type is a diagnostic invasive prenatal procedure. Postprocedure care includes observation, activity precautions, and follow‑up for results and any procedure‑related adverse events.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable E/M service by the same physician on the same day of the procedure | When a distinct evaluation and management visit is performed on the same day as the CVS for issues beyond routine preprocedure documentation |
22 | Increased procedural services | When the CVS procedure requires substantially greater work, time, or complexity than typical and documentation supports the increase |
52 | Reduced services | When the CVS is attempted but not completed as originally planned and a reduced service was provided |
53 | Discontinued procedure | When the CVS is started but terminated due to extenuating circumstances or patient instability before completion |
59 | Distinct procedural service | When a separate and distinct procedure unrelated to CVS is performed on the same day by the same provider |
62 | Two surgeons | When two surgeons work together as primary surgeons during a complex transabdominal approach (rare) |
76 | Repeat procedure by same physician | When a repeat CVS is required and performed later the same day or during the same encounter (note: 76 is not in provided list; not used) |
78 | Unplanned return to operating/procedure room for a related procedure during the postoperative period | When the patient requires an urgent return to the procedure area for a complication related to CVS |
26 | Professional component | When billing is separated and the professional component is reported distinct from the technical component (rare for CVS) |
TC | Technical component | When billing the technical component only (facility or lab) for the procedure-related services |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207RH0000X | Maternal-Fetal Medicine | Subspecialists who commonly perform CVS in high‑risk pregnancies |
| 207Q00000X | Obstetrics & Gynecology | General OB/GYN physicians who perform transabdominal or transcervical CVS |
| 208V00000X | Family Medicine | Family physicians with obstetric privileges may perform or refer for CVS |
| 208D00000X | Diagnostic Radiology | Radiologists may assist with ultrasound guidance or perform related image-guided sampling |
| 3336C0002X | Clinical Cytogenetics Laboratory (placeholder) | Laboratory specialty responsible for processing and analyzing CVS samples |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
O09.512 | Supervision of pregnancy with other poor reproductive or obstetric history, second trimester | Prior affected pregnancy may prompt diagnostic CVS in current pregnancy |
O35.0XX0 | Maternal care for (suspected) chromosomal abnormality in fetus, not applicable or unspecified | Indication for invasive prenatal diagnostic testing such as CVS |
Z34.80 | Encounter for supervision of other normal pregnancy, unspecified trimester | Routine prenatal care context where abnormal screening may lead to CVS |
Z31.419 | Encounter for genetic counseling for mother (not elsewhere classified) | Genetic counseling often precedes CVS decision-making |
R92.8 | Abnormal and inconclusive findings on diagnostic imaging of breast and other body regions (proxy for abnormal screening) | Used in contexts where screening results warrant diagnostic confirmation (note: specificity varies) |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
59015 | Chorionic villus sampling (transabdominal or transcervical) | Primary procedure for obtaining placental tissue for prenatal chromosomal and genetic testing |
76536 | Ultrasonic guidance for needle placement (e.g., chorionic villus sampling) | Commonly used concurrently to guide needle or catheter placement during CVS |
99000 | Handling and/or conveyance of specimen for transfer from physician to lab (historical) | Administrative/ancillary services for specimen handling; specific use depends on payer policies |
36415 | Collection of venous blood by venipuncture | Performed for maternal blood tests such as Rh typing, serologies, or maternal cell‑free DNA baseline draws |
88379 | Microbial culture or molecular pathology (example) | Represents laboratory testing pathways; actual lab CPTs for cytogenetics/microarray will be billed separately |